{"created":"2023-06-20T15:59:41.962245+00:00","id":17703,"links":{},"metadata":{"_buckets":{"deposit":"c740406b-e11d-4c88-9ffb-90bfaab508f7"},"_deposit":{"created_by":45,"id":"17703","owners":[45],"pid":{"revision_id":0,"type":"depid","value":"17703"},"status":"published"},"_oai":{"id":"oai:redcross.repo.nii.ac.jp:00017703","sets":["437:434:491"]},"author_link":["67188","67185","67187","67186","67189","67190","67184"],"item_10002_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018-03-15","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"40","bibliographicPageStart":"35","bibliographicVolumeNumber":"14","bibliographic_titles":[{"bibliographic_title":"八戸赤十字病院紀要"},{"bibliographic_title":"Acta Medica HACHINOHE Institutio Hospitalis Crucis Ruberae","bibliographic_titleLang":"en"}]}]},"item_10002_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"紀要編集小委員会"}]},"item_10002_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0919-8121","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"佐々木, 彩"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"庄子, 忠宏"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"竹下, 亮輔"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"向井田, 理佳"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-05-07"}],"displaytype":"simple","filename":"3 レジメン以上の化学療法歴のある再発卵巣がんにおけるbevacizumab と消化管穿孔の関連.pdf","filesize":[{"value":"2.0 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"hachinohe01","url":"https://redcross.repo.nii.ac.jp/record/17703/files/3 レジメン以上の化学療法歴のある再発卵巣がんにおけるbevacizumab と消化管穿孔の関連.pdf"},"version_id":"72a3ef6b-5ddd-438a-a3f4-217f2b07d56d"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"再発卵巣がん","subitem_subject_scheme":"Other"},{"subitem_subject":"bevacizumab","subitem_subject_scheme":"Other"},{"subitem_subject":"消化管穿孔","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"3 レジメン以上の化学療法歴のある再発卵巣がんにおけるbevacizumab と消化管穿孔の関連","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"3 レジメン以上の化学療法歴のある再発卵巣がんにおけるbevacizumab と消化管穿孔の関連"}]},"item_type_id":"10002","owner":"45","path":["491"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-05-07"},"publish_date":"2021-05-07","publish_status":"0","recid":"17703","relation_version_is_last":true,"title":["3 レジメン以上の化学療法歴のある再発卵巣がんにおけるbevacizumab と消化管穿孔の関連"],"weko_creator_id":"45","weko_shared_id":-1},"updated":"2023-06-20T17:55:48.574207+00:00"}